Found: 7
Select item for more details and to access through your institution.
Mutant p53 Gain-of-Function Induces Migration and Invasion through Overexpression of miR-182-5p in Cancer Cells.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 20, p. 2506, doi. 10.3390/cells12202506
- By:
- Publication type:
- Article
Molecular mechanisms of resveratrol as chemo and radiosensitizer in cancer.
- Published in:
- Frontiers in Pharmacology, 2023, p. 01, doi. 10.3389/fphar.2023.1287505
- By:
- Publication type:
- Article
Proteomic Profiling Reveals That Resveratrol Inhibits HSP27 Expression and Sensitizes Breast Cancer Cells to Doxorubicin Therapy
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0064378
- By:
- Publication type:
- Article
N -(2-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Induces Apoptosis and Cell Cycle Arrest in Breast Cancer Cells, Decreasing GPER Expression.
- Published in:
- Molecules, 2024, v. 29, n. 15, p. 3509, doi. 10.3390/molecules29153509
- By:
- Publication type:
- Article
MPS1 is involved in the HPV16-E7-mediated centrosomes amplification.
- Published in:
- Cell Division, 2021, v. 16, n. 1, p. 1, doi. 10.1186/s13008-021-00074-9
- By:
- Publication type:
- Article
Antimetastatic Effect of Epigenetic Drugs, Hydralazine and Valproic Acid, in Ras-Transformed NIH 3T3 Cells [Corrigendum].
- Published in:
- OncoTargets & Therapy, 2022, v. 15, p. 845, doi. 10.2147/OTT.S382501
- By:
- Publication type:
- Article
Antimetastatic effect of epigenetic drugs, hydralazine and valproic acid, in Ras-transformed NIH 3T3 cells.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 8823, doi. 10.2147/OTT.S187306
- By:
- Publication type:
- Article